Emerging therapies targeting GD2, a marker highly expressed in neuroblastoma, offer tremendous promise. FDA-approved ...

Founded in 1997, VEG built its reputation through its deep engineering expertise across a range of CQV services. The ...

Advarra, a provider of clinical research technology, expanded its Study Collaboration, a study startup technology designed to ...

Buildout includes Gerteis Macro-Pactor install to meet growing demand for complex oral solid dose development and manufacturing.

Stamoulis joins Mallinckrodt from Incyte, a leading biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. In addition ...

Former Vice President and Global Head of Commercial Development of Lonza’s small molecules custom manufacturing business to head up Arcinova.

Welcome to Contract Pharma’s annual ranking of the Top 20 Pharma and Biopharma Companies, based on fiscal year 2024 ...

The expansion increases output, enhancing Axplora’s ability to meet growing global demand for high-value pharmaceutical ...

Developed by Autolus Therapeutics, AUCATZYL is approved to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL). This follows prior authorizations from ...

The Vibativ 4-Vial Starter Pak is an FDA-approved injectable antibiotic indicated to treat HABP/VABP and complicated skin and ...

Solvias, a global provider of chemistry, manufacturing, and controls (CMC) analytical services, appointed Jarlath Keating as ...

To layoff 5,000 employees by the end of the year; aims to reduce operating expenses by approximately $1.5 billion by 2027.